Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2017

25.04.2017 | Gynecologic Endocrinology and Reproductive Medicine

In vitro fertilization when men, women, or both partners are positive for HIV: a case–control study

verfasst von: Pauline Vankerkem, Yannick Manigart, Annick Delvigne, Lieveke Ameye, Deborah Konopnicki, Chloë Shaw-Jackson, Serge Rozenberg, Candice Autin

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to compare the outcomes of in vitro fertilization (IVF) for couples where one or both partners were positive for the human immunodeficiency virus (HIV) to matched control couples.

Methods

A matched case–control retrospective study was performed. Data for 104 couples where the woman was HIV-positive; for 90 couples where the man was HIV-positive; and for 33 couples where both partners were HIV-positive were prospectively analyzed in comparison to matched controls treated in our center during the same period. The main outcomes were clinical pregnancy and live birth rates.

Results

For couples involving an HIV-positive man, clinical outcomes were comparable to controls and resulted in the birth of 18 healthy babies after 90 cycles. When the woman was affected, cycle cancelation, number of retrieved oocytes, and on-going clinical pregnancy rates per transfer were statistically reduced. Implantation rates were comparable to those of non-affected controls. Seven healthy babies for 104 cycles were obtained. For a couple in which both partners were HIV-positive, only one healthy birth occurred after 33 cycles. Pregnancy rates were systematically reduced though not significantly probably due to sample size.

Conclusions

Our data suggest that IVF outcomes were similar to controls when men were HIV-positive and remain acceptable when women were HIV-positive. IVF outcomes were severely reduced in our sero-concordant couples; however, many patients had severe HIV disease previously, and therefore, these results should be reassessed in patients treated early in their disease.
Literatur
2.
Zurück zum Zitat Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 33(4):144–152 (165) CrossRefPubMed Chen JL, Philips KA, Kanouse DE, Collins RL, Miu A (2001) Fertility desires and intentions of HIV-positive men and women. Fam Plann Perspect 33(4):144–152 (165) CrossRefPubMed
3.
Zurück zum Zitat Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372(9635):293–299. doi:10.1016/S0140-6736(08)61113-7 CrossRef Antiretroviral Therapy Cohort Collaboration (2008) Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 372(9635):293–299. doi:10.​1016/​S0140-6736(08)61113-7 CrossRef
4.
Zurück zum Zitat Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340(8831):1317–1319CrossRefPubMed Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, Albani E, Oneta M, Pardi G (1992) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 340(8831):1317–1319CrossRefPubMed
5.
Zurück zum Zitat Sturt AS, Dokubo EK, Sint TT (2010) Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 3:CD008440. doi:10.1002/14651858.CD008440 Sturt AS, Dokubo EK, Sint TT (2010) Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women. Cochrane Database Syst Rev 3:CD008440. doi:10.​1002/​14651858.​CD008440
6.
Zurück zum Zitat Barnes A, Riche D, Mena L, Sison T, Barry L, Reddy R, Shwayder J, Parry J (2014) Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis. Fertil Steril 102(2):424–434. doi:10.1016/j.fertnstert.2014.05.001 (Epub 2014 Jun 18. Review) CrossRefPubMed Barnes A, Riche D, Mena L, Sison T, Barry L, Reddy R, Shwayder J, Parry J (2014) Efficacy and safety of intrauterine insemination and assisted reproductive technology in populations serodiscordant for human immunodeficiency virus: a systematic review and meta-analysis. Fertil Steril 102(2):424–434. doi:10.​1016/​j.​fertnstert.​2014.​05.​001 (Epub 2014 Jun 18. Review) CrossRefPubMed
7.
Zurück zum Zitat Ohl J, Partisani M (2007) The desire to become a parent when infected with human immunodeficiency virus, hepatitis C virus or hepatitis B virus [Article in French]. Gynecol Obstet Fertil 35(10):1035–1038 (Epub 2007 Sep) CrossRefPubMed Ohl J, Partisani M (2007) The desire to become a parent when infected with human immunodeficiency virus, hepatitis C virus or hepatitis B virus [Article in French]. Gynecol Obstet Fertil 35(10):1035–1038 (Epub 2007 Sep) CrossRefPubMed
9.
Zurück zum Zitat Manigart Y, Rozenberg S, Barlow P, Gerard M, Bertrand E, Delvigne A (2006) ART outcome in HIV-infected patients. Hum Reprod 21(11):2935–2940 (Epub 2006 Aug 3) CrossRefPubMed Manigart Y, Rozenberg S, Barlow P, Gerard M, Bertrand E, Delvigne A (2006) ART outcome in HIV-infected patients. Hum Reprod 21(11):2935–2940 (Epub 2006 Aug 3) CrossRefPubMed
10.
Zurück zum Zitat Bertrand E, Zissis G, Marissens D, Gérard M, Rozenberg S, Barlow P, Delvigne A (2004) Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology. AIDS 18(5):823–825CrossRefPubMed Bertrand E, Zissis G, Marissens D, Gérard M, Rozenberg S, Barlow P, Delvigne A (2004) Presence of HIV-1 in follicular fluids, flushes and cumulus oophorus cells of HIV-1-seropositive women during assisted-reproduction technology. AIDS 18(5):823–825CrossRefPubMed
11.
Zurück zum Zitat Gilling-Smith C, Almeida P (2003) Practice and Policy Committee of the British Fertility Society. HIV, hepatitis B and hepatitis C and infertility: reducing risk. Hum Fertil Camb 6(3):106–112CrossRefPubMed Gilling-Smith C, Almeida P (2003) Practice and Policy Committee of the British Fertility Society. HIV, hepatitis B and hepatitis C and infertility: reducing risk. Hum Fertil Camb 6(3):106–112CrossRefPubMed
12.
Zurück zum Zitat Delvigne A, Kostyla K, Murillo D, Van Hoeck J, Rozenberg S (2009) Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48(1):25–31 Delvigne A, Kostyla K, Murillo D, Van Hoeck J, Rozenberg S (2009) Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48(1):25–31
13.
Zurück zum Zitat Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245. doi:10.1093/humupd/dmp048 (Epub 2009 Nov 24) CrossRefPubMed Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, Haugen TB, Kruger T, Wang C, Mbizvo MT, Vogelsong KM (2010) World Health Organization reference values for human semen characteristics. Hum Reprod Update 16(3):231–245. doi:10.​1093/​humupd/​dmp048 (Epub 2009 Nov 24) CrossRefPubMed
14.
Zurück zum Zitat Vandamme AM, Fransen K, Debaisieux L, Marissens D, Sprecher S, Vaira D, Vandenbroucke AT, Verhofstede C (1995) Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods 51(2–3):305–316CrossRefPubMed Vandamme AM, Fransen K, Debaisieux L, Marissens D, Sprecher S, Vaira D, Vandenbroucke AT, Verhofstede C (1995) Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories. J Virol Methods 51(2–3):305–316CrossRefPubMed
15.
Zurück zum Zitat Shaw-Jackson C, Bertrand E, Becker B, Colin J, Beaudoin-Chabot C, Rozenberg S, Autin C (2013) Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming. J Assist Reprod Genet 30(8):1035–1042. doi:10.1007/s10815-013-0037-7 (Epub 2013 Jul 10) CrossRefPubMedPubMedCentral Shaw-Jackson C, Bertrand E, Becker B, Colin J, Beaudoin-Chabot C, Rozenberg S, Autin C (2013) Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming. J Assist Reprod Genet 30(8):1035–1042. doi:10.​1007/​s10815-013-0037-7 (Epub 2013 Jul 10) CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Gardner DK, Schoolcraft WB (1999) In vitro culture of human blastocyst. In: Jansen R, Mortimer D (eds) Towards reproductive certainty: infertility and genetics beyond. Parthernon Press, Carnforth, pp 378–388 Gardner DK, Schoolcraft WB (1999) In vitro culture of human blastocyst. In: Jansen R, Mortimer D (eds) Towards reproductive certainty: infertility and genetics beyond. Parthernon Press, Carnforth, pp 378–388
17.
Zurück zum Zitat Revised surveillance case definition for HIV infection-United States (2014) MMWR Recomm Rep 63(RR-03):1–10 Revised surveillance case definition for HIV infection-United States (2014) MMWR Recomm Rep 63(RR-03):1–10
18.
Zurück zum Zitat Gout C, Rougier N, Oger P, Dorphin B, Kahn V, Jacquesson L, Ayel JP, Yazbeck C (2011) Assisted Reproductive Technologies in HIV patients: a comprehensive review of indications, techniques and results [Article in French]. Gynecol Obstet Fertil 39(12):704–708. doi:10.1016/j.gyobfe.2011.07.029 (Epub 2011 Aug 25) CrossRefPubMed Gout C, Rougier N, Oger P, Dorphin B, Kahn V, Jacquesson L, Ayel JP, Yazbeck C (2011) Assisted Reproductive Technologies in HIV patients: a comprehensive review of indications, techniques and results [Article in French]. Gynecol Obstet Fertil 39(12):704–708. doi:10.​1016/​j.​gyobfe.​2011.​07.​029 (Epub 2011 Aug 25) CrossRefPubMed
19.
Zurück zum Zitat Prisant N, Tubiana R, Lefebvre G, Lebray P, Marcelin AG, Thibault V, Rosenblum O, Bonmarchand M, Vauthier-Brouzes D, Golmard JL, Katlama C, Poirot C (2010) HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome. Fertil Steril 93(3):1020–1023. doi:10.1016/j.fertnstert.2009.07.1663 (Epub 2009 Sep 3) CrossRefPubMed Prisant N, Tubiana R, Lefebvre G, Lebray P, Marcelin AG, Thibault V, Rosenblum O, Bonmarchand M, Vauthier-Brouzes D, Golmard JL, Katlama C, Poirot C (2010) HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome. Fertil Steril 93(3):1020–1023. doi:10.​1016/​j.​fertnstert.​2009.​07.​1663 (Epub 2009 Sep 3) CrossRefPubMed
20.
Zurück zum Zitat Kashima K, Takakuwa K, Suzuki M, Makino M, Kaneko S, Kato S, Hanabusa H, Tanaka K (2009) Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Jpn J Infect Dis 62(3):173–176PubMed Kashima K, Takakuwa K, Suzuki M, Makino M, Kaneko S, Kato S, Hanabusa H, Tanaka K (2009) Studies of assisted reproduction techniques (ART) for HIV-1-discordant couples using washed sperm and the nested PCR method: a comparison of the pregnancy rates in HIV-1-discordant couples and control couples. Jpn J Infect Dis 62(3):173–176PubMed
21.
Zurück zum Zitat Guibert J, Merlet F, Le Dû A, Mandelbrot L, Leruez-Ville M, Costagliola D, Kunstmann J-M, De Almeida M, Heard I, Dulioust E, Rouzioux C, Sicard D, Salmon D, Zorn J-R, Jouannet P (2001) Prise en charge des couples séro-différents pour le VIH. Résultats du protocole NECO (ANRS 092) à Paris. Reprod Hum Horm 14:363–364 Guibert J, Merlet F, Le Dû A, Mandelbrot L, Leruez-Ville M, Costagliola D, Kunstmann J-M, De Almeida M, Heard I, Dulioust E, Rouzioux C, Sicard D, Salmon D, Zorn J-R, Jouannet P (2001) Prise en charge des couples séro-différents pour le VIH. Résultats du protocole NECO (ANRS 092) à Paris. Reprod Hum Horm 14:363–364
22.
Zurück zum Zitat Marina S, Semprini AE, Marina F et al (2003) Results of 219 IVF-ICSI cycles in serodiscordant couples (seropositive men) to HIV-1. Hum Reprod 18(Suppl 1):xviii152 Marina S, Semprini AE, Marina F et al (2003) Results of 219 IVF-ICSI cycles in serodiscordant couples (seropositive men) to HIV-1. Hum Reprod 18(Suppl 1):xviii152
23.
Zurück zum Zitat Mencaglia L, Falcone P, Lentini GM, Consigli S, Pisoni M, Lofiego V, Guidetti R, Piomboni P, De Leo V (2005) ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner. Hum Reprod 20(8):2242–2246CrossRefPubMed Mencaglia L, Falcone P, Lentini GM, Consigli S, Pisoni M, Lofiego V, Guidetti R, Piomboni P, De Leo V (2005) ICSI for treatment of human immunodeficiency virus and hepatitis C virus-serodiscordant couples with infected male partner. Hum Reprod 20(8):2242–2246CrossRefPubMed
24.
Zurück zum Zitat Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, Guarnaccia MM (2009) Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 91(6):2455–2460. doi:10.1016/j.fertnstert.2008.04.013 (Epub 2008 Jun 13) CrossRefPubMed Sauer MV, Wang JG, Douglas NC, Nakhuda GS, Vardhana P, Jovanovic V, Guarnaccia MM (2009) Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 91(6):2455–2460. doi:10.​1016/​j.​fertnstert.​2008.​04.​013 (Epub 2008 Jun 13) CrossRefPubMed
25.
Zurück zum Zitat Savasi V, Ferrazzi E, Lanzani C, Oneta M, Parrilla B, Persico T (2007) Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod 22(3):772–777 (Epub 2006 Nov 15) CrossRefPubMed Savasi V, Ferrazzi E, Lanzani C, Oneta M, Parrilla B, Persico T (2007) Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Hum Reprod 22(3):772–777 (Epub 2006 Nov 15) CrossRefPubMed
26.
Zurück zum Zitat Veiga A, Coll O, Tur R, Busquets A, Barri PN (1999) Assisted reproductive technologies and HIV-1 serodiscordant couples. Prenat Neonat Med 4:356–361 Veiga A, Coll O, Tur R, Busquets A, Barri PN (1999) Assisted reproductive technologies and HIV-1 serodiscordant couples. Prenat Neonat Med 4:356–361
27.
Zurück zum Zitat Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, Vernazza P, Ohl J, Weigel M, Englert Y, Semprini AE (2007) CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21(14):1909–1914CrossRefPubMed Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, Vernazza P, Ohl J, Weigel M, Englert Y, Semprini AE (2007) CREAThE network. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 21(14):1909–1914CrossRefPubMed
28.
Zurück zum Zitat Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186(4):627–633CrossRefPubMed Sauer MV, Chang PL (2002) Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. Am J Obstet Gynecol 186(4):627–633CrossRefPubMed
29.
Zurück zum Zitat Nicopoullos JD, Almeida P, Vourliotis M, Goulding R, Gilling-Smith C (2010) A decade of sperm washing: clinical correlates of successful insemination outcome. Hum Reprod 25(8):1869–1876. doi:10.1093/humrep/deq134 (Epub 2010 Jun 9) CrossRefPubMed Nicopoullos JD, Almeida P, Vourliotis M, Goulding R, Gilling-Smith C (2010) A decade of sperm washing: clinical correlates of successful insemination outcome. Hum Reprod 25(8):1869–1876. doi:10.​1093/​humrep/​deq134 (Epub 2010 Jun 9) CrossRefPubMed
30.
Zurück zum Zitat Sergerie M, Martinet S, Kiffer N, Teulé R, Pasquier C, Bujan L (2004) Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques [Article in French]. Gynecol Obstet Fertil. 32(10):841–849CrossRefPubMed Sergerie M, Martinet S, Kiffer N, Teulé R, Pasquier C, Bujan L (2004) Impact of reverse transcriptase inhibitors on sperm mitochondrial and genomic DNA in assisted reproduction techniques [Article in French]. Gynecol Obstet Fertil. 32(10):841–849CrossRefPubMed
31.
Zurück zum Zitat Van Leeuwen E, Repping S, Prins JM, Reiss P, van der Veen F (2009) Assisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man. Neth J Med 67(8):322-7. Review Van Leeuwen E, Repping S, Prins JM, Reiss P, van der Veen F (2009) Assisted reproductive technologies to establish pregnancies in couples with an HIV-1-infected man. Neth J Med 67(8):322-7. Review
32.
Zurück zum Zitat Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM (2006) Decreased pregnancy rate after in vitro fertilization in HIV-infected women receiving HAART. AIDS 20(1):121–123CrossRefPubMed Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM (2006) Decreased pregnancy rate after in vitro fertilization in HIV-infected women receiving HAART. AIDS 20(1):121–123CrossRefPubMed
33.
Zurück zum Zitat Nurudeen SK, Grossman LC, Bourne L, Guarnaccia MM, Sauer MV, Douglas NC (2013) Reproductive outcomes of HIV seropositive women treated by assisted reproduction. J Womens Health (Larchmt) 22(3):243–249. doi:10.1089/jwh.2012.3855 (Epub 2013 Feb 25) CrossRef Nurudeen SK, Grossman LC, Bourne L, Guarnaccia MM, Sauer MV, Douglas NC (2013) Reproductive outcomes of HIV seropositive women treated by assisted reproduction. J Womens Health (Larchmt) 22(3):243–249. doi:10.​1089/​jwh.​2012.​3855 (Epub 2013 Feb 25) CrossRef
34.
Zurück zum Zitat Terriou P, Auquier P, Chabert-Orsini V, Chinchole JM, Cravello L, Giorgetti C, Halfon P, Salzmann J, Roulier R (2005) Outcome of ICSI in HIV-1-infected women. Hum Reprod 20(10):2838–2843 (Epub 2005 Jun 24) CrossRefPubMed Terriou P, Auquier P, Chabert-Orsini V, Chinchole JM, Cravello L, Giorgetti C, Halfon P, Salzmann J, Roulier R (2005) Outcome of ICSI in HIV-1-infected women. Hum Reprod 20(10):2838–2843 (Epub 2005 Jun 24) CrossRefPubMed
35.
Zurück zum Zitat Martinet V, Manigart Y, Rozenberg S, Becker B, Gerard M, Delvigne A (2006) Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study. Hum Reprod 21(5):1212–1217 (Epub 2006 Jan 26) CrossRefPubMed Martinet V, Manigart Y, Rozenberg S, Becker B, Gerard M, Delvigne A (2006) Ovarian response to stimulation of HIV-positive patients during IVF treatment: a matched, controlled study. Hum Reprod 21(5):1212–1217 (Epub 2006 Jan 26) CrossRefPubMed
36.
Zurück zum Zitat Englert Y, Lesage B, Van Vooren JP, Liesnard C, Place I, Vannin AS, Emiliani S, Delbaere A (2004) Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update 10(2):149–62 (Review) Englert Y, Lesage B, Van Vooren JP, Liesnard C, Place I, Vannin AS, Emiliani S, Delbaere A (2004) Medically assisted reproduction in the presence of chronic viral diseases. Hum Reprod Update 10(2):149–62 (Review)
37.
Zurück zum Zitat Ohl J, Partisani M, Demangeat C, Binder-Foucard F, Nisand I, Lang JM (2010) Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women. [Article in French]. Gynecol Obstet Fertil 38(5):313–317. doi:10.1016/j.gyobfe.2009.07.019 (Epub 2010 Apr 28) CrossRefPubMed Ohl J, Partisani M, Demangeat C, Binder-Foucard F, Nisand I, Lang JM (2010) Alterations of ovarian reserve tests in Human Immunodeficiency Virus (HIV)-infected women. [Article in French]. Gynecol Obstet Fertil 38(5):313–317. doi:10.​1016/​j.​gyobfe.​2009.​07.​019 (Epub 2010 Apr 28) CrossRefPubMed
Metadaten
Titel
In vitro fertilization when men, women, or both partners are positive for HIV: a case–control study
verfasst von
Pauline Vankerkem
Yannick Manigart
Annick Delvigne
Lieveke Ameye
Deborah Konopnicki
Chloë Shaw-Jackson
Serge Rozenberg
Candice Autin
Publikationsdatum
25.04.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2017
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-017-4374-0

Weitere Artikel der Ausgabe 6/2017

Archives of Gynecology and Obstetrics 6/2017 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.